MXPA99003430A - Enzymatic production of vitamin - Google Patents
Enzymatic production of vitaminInfo
- Publication number
- MXPA99003430A MXPA99003430A MXPA/A/1999/003430A MX9903430A MXPA99003430A MX PA99003430 A MXPA99003430 A MX PA99003430A MX 9903430 A MX9903430 A MX 9903430A MX PA99003430 A MXPA99003430 A MX PA99003430A
- Authority
- MX
- Mexico
- Prior art keywords
- ifo
- vitamin
- dtp
- reaction system
- corynebacterium
- Prior art date
Links
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 27
- 239000011782 vitamin Substances 0.000 title claims abstract description 27
- 229930003231 vitamins Natural products 0.000 title claims abstract description 27
- 229940088594 Vitamin Drugs 0.000 title claims abstract description 26
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 230000002255 enzymatic Effects 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 21
- 244000005700 microbiome Species 0.000 claims abstract description 21
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims abstract description 20
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 20
- 229950006238 nadide Drugs 0.000 claims abstract description 20
- ZKJOXOJMGXFSPF-QYZPTAICSA-N [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;hydrate Chemical compound O.NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 ZKJOXOJMGXFSPF-QYZPTAICSA-N 0.000 claims abstract description 18
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 10
- 241000607720 Serratia Species 0.000 claims abstract description 10
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 10
- 229910001437 manganese ion Inorganic materials 0.000 claims abstract description 10
- 241000235070 Saccharomyces Species 0.000 claims abstract description 9
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims abstract description 8
- 241001468125 Exiguobacterium Species 0.000 claims abstract description 8
- 229940039696 Lactobacillus Drugs 0.000 claims abstract description 8
- 241000186660 Lactobacillus Species 0.000 claims abstract description 8
- 241000235648 Pichia Species 0.000 claims abstract description 8
- 241000186063 Arthrobacter Species 0.000 claims abstract description 7
- 241000186146 Brevibacterium Species 0.000 claims abstract description 7
- 241000186216 Corynebacterium Species 0.000 claims abstract description 7
- 241000588914 Enterobacter Species 0.000 claims abstract description 7
- 241000589565 Flavobacterium Species 0.000 claims abstract description 7
- 241000588748 Klebsiella Species 0.000 claims abstract description 7
- 241000589180 Rhizobium Species 0.000 claims abstract description 7
- 241000589516 Pseudomonas Species 0.000 claims abstract description 6
- 241001135312 Sinorhizobium Species 0.000 claims abstract description 6
- 241000611330 Chryseobacterium Species 0.000 claims abstract description 5
- 241000588722 Escherichia Species 0.000 claims abstract description 5
- 241000122971 Stenotrophomonas Species 0.000 claims abstract description 4
- JBNUARFQOCGDRK-GBXIJSLDSA-N 4-hydroxy-L-threonine zwitterion Chemical compound [O-]C(=O)[C@@H]([NH3+])[C@H](O)CO JBNUARFQOCGDRK-GBXIJSLDSA-N 0.000 claims abstract description 3
- 241000196324 Embryophyta Species 0.000 claims abstract description 3
- 241001465754 Metazoa Species 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 3
- 235000013373 food additive Nutrition 0.000 claims abstract description 3
- 239000002778 food additive Substances 0.000 claims abstract description 3
- 235000016709 nutrition Nutrition 0.000 claims abstract description 3
- 230000035764 nutrition Effects 0.000 claims abstract description 3
- IGUZJYCAXLYZEE-RFZPGFLSSA-N 1-deoxy-D-xylulose Chemical compound CC(=O)[C@@H](O)[C@H](O)CO IGUZJYCAXLYZEE-RFZPGFLSSA-N 0.000 claims abstract 4
- XMSHRLOQLUNKSN-UHFFFAOYSA-N 4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-5-hydroxypyrazole Chemical compound CC1=NN(C)C(O)=C1C(=O)C1=CC=C(Cl)C=C1Cl XMSHRLOQLUNKSN-UHFFFAOYSA-N 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 23
- 229960001456 Adenosine Triphosphate Drugs 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 6
- 241000186145 Corynebacterium ammoniagenes Species 0.000 claims description 5
- 241000235048 Meyerozyma guilliermondii Species 0.000 claims description 5
- 241000589196 Sinorhizobium meliloti Species 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 229940119563 Enterobacter cloacae Drugs 0.000 claims description 3
- 241000588697 Enterobacter cloacae Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241001524188 Glutamicibacter nicotianae Species 0.000 claims description 3
- 241000122973 Stenotrophomonas maltophilia Species 0.000 claims description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 2
- 241000131747 Exiguobacterium acetylicum Species 0.000 claims description 2
- XJLXINKUBYWONI-NNYOXOHSSA-N Nicotinamide adenine dinucleotide phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims description 2
- 229940098362 Serratia marcescens Drugs 0.000 claims description 2
- 241000607715 Serratia marcescens Species 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims 1
- 229930003629 Vitamin B6 Natural products 0.000 abstract description 8
- 229940011671 Vitamin B6 Drugs 0.000 abstract description 8
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 8
- 239000011726 vitamin B6 Substances 0.000 abstract description 8
- 150000003697 vitamin B6 derivatives Chemical class 0.000 abstract description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 13
- LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 10
- 239000002609 media Substances 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 7
- VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dimercaptobutane-2,3-diol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229930003270 Vitamin B Natural products 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000001963 growth media Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- PHIQHXFUZVPYII-UHFFFAOYSA-N Carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 4
- GLFNIEUTAYBVOC-UHFFFAOYSA-L MANGANESE CHLORIDE Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 4
- 229910021380 MnCl2 Inorganic materials 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 239000011565 manganese chloride Substances 0.000 description 4
- 235000002867 manganese chloride Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229940041514 Candida albicans extract Drugs 0.000 description 3
- 241000589589 Chryseobacterium indologenes Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 229940023064 Escherichia coli Drugs 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 2
- 229940116542 OTHER NUTRIENTS in ATC Drugs 0.000 description 2
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- -1 phenylmethylsulfonyl Chemical group 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- DVARTQFDIMZBAA-UHFFFAOYSA-O Ammonium nitrate Chemical compound [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 1
- 240000008371 Bacillus subtilis Species 0.000 description 1
- 229940075615 Bacillus subtilis Drugs 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 229960003581 Pyridoxal Drugs 0.000 description 1
- 241000588746 Raoultella planticola Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 101710010750 XV Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FOGVNFMUZXDMTR-UHFFFAOYSA-N [Mg].Cl Chemical class [Mg].Cl FOGVNFMUZXDMTR-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000009632 agar plate Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- PPBAJDRXASKAGH-UHFFFAOYSA-O azanium;urea Chemical compound [NH4+].NC(N)=O PPBAJDRXASKAGH-UHFFFAOYSA-O 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002906 microbiologic Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000005429 turbidity Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
A procedure for the enzymatic production of vitamin B6, which comprises the incubation of 1-deoxy-D-threo-pentulose and 4-hydroxy-L-threonine with an enzyme reaction system prepared from cells of a microorganism belonging to the genus Rhizobium, Sinorhizobium, Flavobacterium, Chryseobacterium, Lactobacillus, Arthrobacter, Bacillus, Klebsiella, Escherichia, Pseudomonas, Stenotrophomonas, Enterobacter, Serratia, Corynebacterium, Brevibacterium, Exiguobacterium, Saccharomyces, Yamadazma, Pichia or Candida, in the presence of NADP +, NAD +, ATP. The manganese and magnesium ions stimulate the previous reaction. This procedure provides high yields of vitamin B6, an essential vitamin for the nutrition of animals, plants and microorganisms, and useful as a medicine or food additive.
Description
g
DESCRIPTION OF THE INVENTION
This invention relates to a process for the enzymatic production of vitamin B, from l-deoxy-D-threo-pentulose (hereinafter, called DTP), and 4-hydroxy-L-threonine ( HT). The term "vitamin Bß" as used in the present invention, includes pyridoxol, pyridoxal and pyridoxamin. Vitamin Bt is one of the essential vitamins for the nutrition of animals, plants and microorganisms, and is also very important as a medicine or as a food additive for human beings. The object of the present invention is to provide a highly efficient process for the enzymatic production of vitamin Bβ from DTP and HT. There are many studies on the fermenting of vitamin B6. Several microorganisms belonging to the genus Saccharomyces [G.H. Scherr and M.E. Rafelson, J. Appl. Bacteriol. 25., 187-194 (1962)], Pichia [N. Nishino, K. Fujii, and T. Kamikubo, Agrie. Biol. Chem. 7, 553-559 (1973)], klebsiella [R. Suzue and Y. Haruna, J. Vitaminol. 1 £, 154-159 (1970)], AchromoJbacter [M. Ishida and K. Shimura, Agrie. Biol. Chem. 2 £, 327-334 (1970)], Bacillus [W. Pflug and F. Lingens, Hoppe-Seyler's Z. Physiol. Chem. 359. 559-570 (1978)] and Flavofcacterium [Y. Tani, T. Nakamatsu, T. Izumi and K. Ogata, Agrie. Biol. Chem. £, 189-197 (1972)] are known as producers of vitamin Bt. However, to date, no fermentation process has been known to be commercially attractive for the production of vitamin Bt. More recently, European patent application 0 756 938 A2 has described a process for obtaining by fermentation of vitamin Bβ by cultivating a microorganism belonging to the genus Rhizobium capable of producing said vitamin in a culture medium under conditions aerobic; the culture medium may contain, apart from sources of assimilable carbon and digestible nitrogen, inorganic salts and other nutrients, as well as substances that increase the titre of vitamin Bß, such as DTP and HT. Although this most recently known procedure produces vitamin Bß with high yield, there is room for improvement of its efficacy. The present invention makes possible the production of vitamin Bβ from DTP and HT with an efficiency superior to that achieved so far. It has been discovered that the cell-free extract prepared from cells of a microorganism of the genus RhizoJbium, Sinorhizobiu, Flavobac-teriu, Chryseobacterium, Lactobacillus, Arthrobacter, Bacillus, Klebsiella, Eecherichia, Pseudomonas, Stenotrophomo-nas, Enterobacter, Serratia, Corynebacteriu , Brevibacte-riu, Exiguobacterium, Saccharomyces, Yamadazma, Pichia 6 Candida, is able to produce vitamin Bβ from DTP and HT in the presence of nicotinamide adenine dinucleotide phosphate (NADP *), nicotinamide adenine dinucleotide (NAD *) and adenosine triphosphate (ATP). Thus, the present invention relates to a process for the enzymatic production of vitamin B6 from DTP and HT comprising the contacting of DTP and HT with an enzyme reaction system prepared from cells of a microorganism capable of producing vitamin B, from the DTP and the HT, making said contact in the presence of NADP *, NAD * and ATP. The present invention further relates to a process for the enzymatic production of vitamin B, comprising contacting DTP and HT with an enzyme reaction system containing the cell-free extract derived from a microorganism capable of producing vitamin Bß, belonging to the genus Rhizobium, Sinorhizobium, Flavobacteriupi, Chxyseojbacterium, Lactobacillus, Arthrobacter,
Bacillus, Klebsiella, Escherichia, Pseudomonas, Stenotrophoonas, Enterobacter, Serratia, Corynebacterium, Brevibacteurium, Exiguobacterium, Saccharomyces, Yamadazma, Pichia 6 Candida, in the presence of NADP *, NAD * and ATP. The vitamin B content of a reaction mixture can be determined by a bioassay with Saccharomyces carlsbergensis ATCC 9080 according to the method of D.R. Osborne and P. Voogt [The Analysis of Nutrients in Foods], Academic Press, London, 224-227 (1978)]. To carry out the procedure of this
Invention, cells of the microorganism, e.g. ex. belonging to the genus Rhizobium, Sinorhizobium, Flavobacterium, Chryseobacterium, Lactobacillus, Arthrobacter, Bacillus, Klebsiella, Escherichia, Pseudomonas, Stenotropomonas, Enterobacter, Serratia, Corynebacterium, Brevibacteurium, Exiguobacterium, Saccharomyces, Yamadazma, Pichia 6 Candida, cultivating said microorganism in a medium containing sources of assimilable carbon, sources of digestible nitrogen, inorganic salts and other nutrients necessary for the growth of microorganisms. As carbon sources, for example, glucose, fructose, lactose, galactose, sucrose, maltose, starch, dextrin and glycerin can be used. As nitrogen sources, for example, peptone, yeast extract, soybean meal, corn germ extract, meat extract, ammonium sulfate, ammonium nitrate, urea, and mixtures thereof can be employed. In addition, as inorganic salts, sulfates, hydrochlorides or phosphates of calcium, magnesium, zinc, manganese, cobalt and iron can be used. And if necessary, conventional nutrient factors or an antifoaming agent such as an animal oil, vegetable oil or mineral oil may also be included in the culture medium. The pH of the culture medium can be from about 5 to about 9, preferably from about 6 to about 8. The temperature range suitable for the culture is from about 10 ° C to about 45 ° C, preferably from about 25 ° C. ° C at approximately 40 ° C. The duration of the culture is usually from about 1 to about 5 days, preferably from about 1 to about 3 days. Aeration and agitation during cultivation usually gives favorable results. Microorganisms that can be used in the process of the present invention include all strains belonging to the genera JuizoJbium, Sinorhizobium, Fia-voJbacterium, Chryseobacterium, Lactobacillus, Arthrobacter, Bacillus, Klebsiella, Escherichia, Pseudomonae, Stenotrophoonas, Enterobacter, Serratia, Corynebacterium, Brevibacte-rium, Exiguobacterium, Saccharomyces, Yamadazma, Pichia and Candida. These microorganisms can be purchased in a public warehouse (crop collection) at the request of anyone, such as p. ex. the Institute of Fermentation ("Fermentation Institute"), Osaka, Japan (IFO); examples of said deposited strains are Rhizobium meliloti (also known as S'inorJuzoJbiupi jpeliloti) IFO 14782 (DSM nß 10226), Flavobacterium indologenes (also known as Chryseobacterium indologenes, IFO 14944, Lactobacillus Jbre-vis IFO 13110, Arthrobacter nicotianae IFO 14234, Bacillus subtilis IFO 3007, Klebsiella planticola IFO 3317, Escheri -chia coli IFO 13168, Pseudomonas putida IFO 3738, Stenotro-phomonas maltophilia (also known as Pseudomonas maltophilia or Xanthimonas maltophilia) IFO 12692, Enterobacter cloacae IFO 3320, Serratia marcescens IFO 12648, Corynebacterium ammoniagenes (also known as Brevibacterium ammoniagrenes) IFO 12612, Corynebacterium gruptainicum) (also known as Brevibacterium glutamicum) IFO 12168, Exigrubacteritum acetylicup? (also known as Brevibacterium acetylicum IFO 12146, Pichia guilliermondii (also known as Ya adazyma guilliermondii) IFO 10106, Saccha-romyces cerevisiae IFO 0304 and IFO 0306 and Candida tropicalis IFO 0199 and IFO 0587. Among these microorganisms, they are preferably used in the present invention: Rhizobium meliloti IFO 14782 (DSM No. 10226), Flavobacterium indologenee IFO 14944, Bacillus eubtilis IFO 3007, Escherichia coli IFO 13168, Serratia arceecens IFO 12648, Corynebacterium ammo-niagenes IFO 12612, Corynebacterium glutamicum IFO 12168, Pichia guilliermondii IFO 10106 , Saccharo? Yces cerevisiae IFO 0306. For the preparation of the cell-free extract of cells obtained by culture, general methods such as ultrasonic treatment and cell breakage in the presence of glass beads or by the French homogenizer under pressure can be applied If desired, treatment with a lytic enzyme such as lysozyme or zymolase from 15 ° C to 45 ° C, preferably at 20 ° C to 40 ° C for 1 to 3 hours, may also be applied, prior to disintegration in the above mentioned way. For example, after centrifugation of the culture broth, the resulting cells are washed with saline and suspended in a buffer such as Tris-HCl buffer (pH 7.5) containing sucrose, dithiothreitol (DTT) and fluoride. phenylmethylsulfonyl (PMSF) as general stabilizers of the enzymes. After cell disruption, the resulting solution is centrifuged to separate cell debris, and the supernatant can be used as a cell-free extract. The enzyme reaction system contains the cell-free extract as prepared above or those partially purified by general methods for the purification of enzymes such as precipitation with ammonium sulfate or gel permeation chromatography. Alternatively, the re-sidual cells or the growing cells of the microorganism can also be used. In addition to the cell-free extract, DTP and HT are added as substrates and also NADP *, NAD * and ATP as cofactors, to the reaction system. The amount of DTP, HT, NADP *, NAD * and ATP that must be added to the system may vary depending on the reaction system used. However, in general, the concentrations of DTP, HT, NADP *, NAD * and ATP in the enzyme reaction system are 0.1 mM or more, preferably from 1 mM to 10 mM for DTP and HT; preferably from 0.05 mM to 5 mM, and more preferably from 0.2 mM to 0.4 mM, for NADP * and NAD *; and preferably from 1 mM to 20 mM, and more preferably from 3 mM to 7 mM for ATP. The addition of manganese ions or magnesium ions to the enzyme reaction system stimulates the reaction, and the addition of both ions produces even better results. As salts supplying these ions, for example, the manganese and magnesium hydrochlorides, sulphates, nitrates or phosphates can be used. The amount of manganese ions and magnesium ions to be added may also vary depending on the reaction system employed. However, in general, the concentrations of manganese ions and magnesium ions are in the case of. manganese ions, from 0.1 mM to 100 mM, preferably from approximately 5 mM to 10 M, and in the case of magnesium ions, from 3 mM to 300 mM, preferably from 20 mM to 50 mM. To initiate the enzymatic reaction, a buffer solution that has no influence on the production of vitamin Bβ from DTP and HT can be used. The Tris-HCl buffer is preferably used for this purpose. The enzymatic reaction takes place effectively in a pH range of 6.0 to 8.5, and more preferably in the range of 7.0 to 8.0. The reaction temperature is suitable from 15 ° C to 45 ° C, more preferably from 20 ° C to 40 ° C. The incubation period can be varied depending on the reaction conditions, although it is generally from 30 minutes to 5 hours, more preferably from 2 hours to 4 hours. Vitamin Bt obtained from DTP and HT under the conditions described above, can be easily recovered as follows: For example, after the reaction, the proteins of the reaction mixture are precipitated by heat denaturation, acid, alkali or an organic solvent and separated by centrifugation. For this purpose, a procedure generally used for extracting a certain product from the superior supernatant, which is applicable to the various properties of vitamin Bß, can be applied. For example, the vitamin Bß in the supernatant is purified with an ion exchange resin. The desired product is subsequently recrystallized with a mixture of alcohol and water. The present invention will be illustrated in more detail by the following examples; however, it should be understood that the present invention is not limited to these particular examples.
Preparation of the cell-free extract The Rhizobium meliloti IFO 14782 (DSM No. 10226) was cultured in a seed medium containing 1% glucose, 0.5% polypeptone. { Nippon Seiyaku Co., Japan), 0.2% yeast extract (Difco), 0.05% MgSO4.7H20, 0.001% MnS04.5H20 and 0.001% FeS04.7H20 at 28 'C for 17 hours. The seed culture was transferred to a 500 ml flask containing 200 ml of a fermentation medium containing 4% glucose, 2% polypeptone, 0.2% yeast extract, 0.05% MgSO4.7H20, 0.05% of MnS04.5H20, 0.0001% of FeS04.7H20, and one drop of antifoam CA-115 (Nippon Yushi Co., Japan), and then the bottle was shaken on a shaker of flasks at 28 ° C . After cultivation for 72 hours, the cells were harvested from 400 ml of the culture broth by centrifugation at 10,400 xg for 10 minutes and washed twice with 0.85% NaCl solution and once with 10 mM. Tris-HCl buffer (pH 7.5) containing 15% sucrose, 0.1 mM PMSF and 1 mM DTT and stored at -30 ° C until needed for the preparation of the cell-free extract. The following operation was carried out completely in ice water or at 4 ° C. Cells stored at -30 ° C were thawed and suspended in 5 ml of 10 mM Tris-HCl buffer (pH 7.5) containing 15% sucrose, 0.1 M PMSF and 1 mM DTT. The cell suspension was passed through a French homogenizer under pressure (Ohtake Works Co., Ltd.) at 200 kg / cm2. The resulting homogenate was centrifuged at 34,800 x g for 30 minutes to separate cell debris. Next, ten milliliters of the supernatant ID was dialyzed overnight against 1 liter of 80% ammonium sulfate solution containing 15% sucrose, 0.1 mM PMSF and 1 mM DTT, and the precipitate was collected by centrifugation at 34,800 xg for 30 minutes. The precipitate was dissolved in 10 milliliters of 10 mM Tris-HCl buffer (pH 7.5) containing 15% sucrose and 0.1 mM PMSF, dialysed overnight against the same buffer, dialyzed solution it was stored at -30 ° C until it was needed for the enzymatic reaction The protein content of the cell-free extract was determined by Lowry's method [Lowry et al., J. Biol. Chem. 193. 265 (1951 )] and it was 11.4 mg / ml E1emolo 2 Enzymatic production of vitamin B, from DTP and HT The enzymatic reaction was carried out by means of incubation tubes containing 500 μl of the reaction mixture listed in the Table 1 to 28 ° C. A complete reaction system contained 2.5 mM DTP, 2.5 mM HT, 0.38 mM NADP *, 0.38 M NAD *, 5 mM ATP, 193.25 μl of the cell-free extract and 80 mM Tris-HCl buffer, pH 7.50 After an incubation of 2 hours, the reaction was stopped, heating in a boiling water bath for 3 minutes, it was centrifuged at 10,000 xg for 10 minutes and then the supernatant was treated with phosphatase by incubation of a tube containing 15 μl of the supernatant, 10 μl of 1 mg / ml of acid phosphatase (Boehringer Mannheim GmbH, Germany) and 10 μl of 100 mM acetate buffer (pH 5.0) at 37 ° C for 30 minutes. After incubation, 1,800 μl of water was added to the tube and determined by the microbiological method using the Saccharomyces carlsbergeneie ATCC 9080 as described below. The standard solutions of pyridoxol (0.2 μg per milliliter) were diluted to 1.21 x 10"2 in distilled water, 100 μl of the diluted standard solution or sample and 3 ml of the test medium for the vitamin were added. Bß (Ni-ssui Co., Japan) containing the Saccharomycee carlebergen-sis ATCC 9080, to the tubes in the order indicated and incubated at an angle of 30 ° to 28 ° C. After an incubation of 17 hours, interrupted cell growth by adding 5 ml of 0.1 N hydrochloric acid, and then the absorbance of the samples was measured at 660 nm The amount of vitamin B6 in a sample was determined by comparing the turbidity of the sample with the curve Growth standard of Saccharomycee carlebergeneie ATCC 9080. As a result, 97 ng of vitamin Bß / ml / mg protein / hour was obtained in the complete reaction system., no vitamin Bs were produced in the reaction systems in which a complete system factor was missing. In addition, 119, 123 or 587 ng of vitamin B6 / ml / mg of protein / hour were obtained in the system supplemented with 8.4 mM of MnCl2, 32 mM of MgCl2, or both, respectively, to the complete system (table 1) . The results indicated that the cell-free extract, NADP *, NAD * and ATP are essential for the production of vitamin B6 from DTP and HT, and that MnCl2 and MgCl2 stimulate production.
Table 1. Enzymatic production of vitamin Bß from DTP and HT
Complete: 2.5 mM DTP, 2.5 mM HT, 0.38 mM NADP *, 0.38 mM NAD *, 5 mM ATP, 193.25 μL cell-free extract, and 80 mM of Tris-HCl buffer, pH 7.50 Example 3 In a manner similar to that described in example 1 and 2, the production of vitamin B6 was examined by cell-free extracts of various kinds of microorganisms. A loop filled with cells grown on an agar plate of each strain listed in Table 2 was grown in each seed medium at 28 ° C for 17 hours. Two milliliters of the seed culture were transferred into a 500 ml flask containing 100 ml of the bulk medium and one drop of antifoam, and then stirred in a flask shaker at 28 ° C. The compositions of the seeding medium and the bulk medium for the culture of each strain listed in Table 2 are summarized in Table 3. Table 2. Microorganisms and their culture medium
Table 3. Media compositions
After a 24-hour culture, the cells of each strain were harvested from 400 ml of culture broth by centrifugation and washed twice with 0.85% NaCl solution and once with 10 mM Tris-buffer. HCl (pH 7.5) containing 15% sucrose, 0.1 mM PMSF and 1 mM DTT. The resulting cells were suspended in 5 ml of the same buffer. Cells of Flavobacterium indologenes IFO 14944, Lactobacillus brevis IFO 13110, Arthrobacter nicotianae IFO 14234, Bacillus eubtilie IFO 3007, Klebeiella planticola IFO 3317, Eecherichia coli IFO 13168, Peeudomonas putida IFO 3738, Stenotrophomonae mal tophilia IFO 12692, Enterobacter cloacae IFO 3320 or Serratia arcescene IFO 12648, were disintegrated by passing them through a French homogenizer under pressure or by ultrasonic disintegration (Cosmo Bio Co., Ltd.) and others, treated with 2 mg of lysozyme (Sigma) or 200 units of zymolase (Sigma) / ml of cell suspension at 30 ° C for 1 hour before disintegration as shown in Table 4. The resulting homogenate was centrifuged to remove cellular debris, and the supernatant was dialyzed against 10 mM Tris-HCl buffer ( pH 7.5) containing 15% sucrose and 0.1 mM PMSF and used as a cell-free extract. The enzymatic reaction was carried out by incubating a tube with 500 μl of reaction mixture A containing 2.5 mM DTP, 2.5 mM HT, 0.38 mM NADP *, 0.38 M NAD * , 5 mM of ATP, 193.25 μL of cell-free extract, and 80 mM of Tris-HCl buffer, pH 7.50, or reaction mixture B supplemented with 8.4 mM of MnCl2 and 32 mM of MgCl2 28 ° C. After incubation for 2 hours, the reaction was stopped by heating in a boiling aryan bath for 3 minutes, the mixture was centrifuged at 10,000 x g for 10 minutes and the supernatant was treated with acid phosphatase at 37 ° C. After an incubation for 30 minutes, the vitamin Bs produced in the reaction mixture was determined by the bioassay method using the Saccharomy-ees carlebergeneie ATCC 9080. As a result, 7-23 and 33-139 ng of vitamin Bß were obtained / ml / mg protein / hour, in reaction mixture A and B respectively, as summarized in Table 4.
Table 4. Production of vitamin Bß by the F cell-free extract: Press French U: Ultrasonic disintegration *: Treatment with 2 mg of lysozyme (Sigma) / ml of cell suspension at 30 ° C for 1 hour before disintegration **: Treatment with 200 units of zymolase (Sigma) / ml of cell suspension
° C for 1 hour before disintegration. Reaction mixture A: 2.5 mM DTP, 2.5 mM HT, 0.38 mM NADP *, 0.38 mM NAD +, 5 mM ATP, cell-free extract, and 80 mM Tris buffer -HCl, pH 7.50, in a total volume of 500 μl. Reaction mixture B: 2.5 mM DTP, 2.5 mM HT, 0.38 mM NADP +, 0.38 mM NAD +, 5 mM ATP, 8.4 mM MnCl2, 32 mM MgCl2, cell-free extract, and 80 mM Tris-HCl buffer, pH 7.50, in a total volume of 500 μl.
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Claims (8)
1. A procedure for the production of the vitamin Bß from 1-deoxy-D-threo-pentulose (DTP) and 4-r, hydroxy-L-threonine (HT), characterized in that it comprises contacting the DTP and the HT with a reaction system enzyme prepared from cells of a microorganism capable of producing vitamin Bβ from DTP and HT, said contact taking place in the presence of nicotinamide adenine dinucleotide phosphate (NADP *), nicotinamide adenine dinucleotide (NAD *), and adenosine triphosphate (ATP).
2. A method according to claim 1, characterized by the uuuai cres of DTP, HT, NADP *, NAD *, and
ATP in the enzyme reaction system is 0.1 mM or more, preferably from 1 mM to 10 mM for DTP and HT; preferably from 0.05 mM to 5 mM and more preferably from 0.2 mM to 0.4 mM for the NADP * and NAD *; and preferably from 1 mM to 20 mM, more preferably from 3 mM to 7 mM for ATP. 3. A process according to claim 1 or 2 characterized in that the enzyme reaction system also contains manganese ions, magnesium ions, or a mixture of both magnesium and manganese ions.
4. A process according to claim 3, characterized in that the concentrations of manganese ions and magnesium ions are, in the case of manganese ions, from 0.1 mM to 100 mM, preferably from 5 mM to 10 mM. mM, and in the case of magnesium ions, from 3 mM to 300 mM, preferably, from 20 mM to 50 mM.
5. A process according to any one of claims 1 to 4, characterized in that the enzymatic reaction for preparing the enzymatic reaction system is carried out in a pH range of 6.0 to 8.5, preferably 7.0 to 8. , 0, and in a temperature range of 15 ° C to 45 ° C, preferably, from 20 ° C to 40 ° C, for 30 minutes to 5 hours, preferably for 2 hours to 4 hours.
6. A process according to any one of claims 1 to 5, characterized in that the enzyme reaction system contains the cell-free extract derived from a microorganism belonging to the genus Rhizobium, Sinorhizobium, Flavobacterium, Chryeeobacteriu, Lactobacillue, Arthrobacter, Bacillue, Klebeiella, Eecheri -chia, Pseudomonas, Stenotrophomonas, Enterobacter, Serratia, Corynebacterium, Brevibacterium, Exiguobacterium, Saccharomycee, Yamadazma, Pichia or Candida.
7. A procedure according to the claim 6, characterized in that the enzyme reaction system contains a cell-free extract, derived from one or more of Rhizo-bium meliloti (also known as Sinorhizobium meliloti) IFO 14782 (DSM No. 10226), Flavobacterium indologenee (also known as Chryeeobacterium indologenee) ) IFO 14944, Lactobacillus brevie IFO 13110, Arthrobacter nicotianae IFO 14234, Bacillus eubtilie IFO 3007, Klebeiella planticola IFO 3317, Eecherichia coli IFO 13168, Peeudomonae putida IFO 3738, Stenotrophomonas maltophilia (also known as Peeudomonae maltophilia or Xanthomonae maltophilia) IFO 12692, Enterobacter cloacae IFO 3320, Serratia arcescene IFO 12648, Corynebacterium ammoniagenes (also known as Brevibacterium ammoniagenes) IFO 12612, Coxynebacterium glutamicum (also known as Brevibacterium glutamicum) IFO 12168, Exiguobacterium acetylicu (also known as Brevibacterium acetylicum IFO 12146, Pichia guilliermondii (also known as Yamadazyma guilliermondii) IFO 10106, Saccharomyces cerevieiae IFO 0304 and IFO 0306 and Candida tropicalie IFO 0199 and IFO 0587.
8. A process according to claim 7, characterized in that the enzyme system contains a cell-free extract derived from one or more of Rhizobium. meliloti IFO 14782 (DSM No. 10226), Flavobacterium indologenee IFO 14944, Bacillue eubtilie IFO 3007, Escherichia coli IFO 13168, Serratia marcescens IFO 12648, Corynebacterium ammo-niagenes IFO 12612, Corynebacterium glutamicum IFO 12168, Pichia guilliermondii IFO 10106, and Saccharomycee cerevieiae IFO 0306. SUMMARY] OF THE INVENTION A procedure for the enzymatic production of vitamin Bß, which includes the incubation of 1-deoxy-D-threo-pentulose and 4-hydroxy-L-threonine with an enzyme reaction system prepared from cells of a microorganism belonging to the genus Rhizobium, Sinorhizobium, Flavobacterium, Chryseobacterium, Lactobacillus, Arthrobacter, Bacillus, Klebsiella, Escherichia, Pseudomonas, Stenotrophomonas, Enterobacter, Serratia, Corynebacterium, Brevibacterium, Exiguobacterium, Saccharomyces, Yamadazma, Pichia or Candida, in the presence of NADP *, NAD *, ATP. The manganese and magnesium ions stimulate the previous reaction. This procedure provides high yields of vitamin Bß, an essential vitamin for the nutrition of animals, plants and microorganisms, and useful as a medicine or food additive.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98106812.5 | 1998-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99003430A true MXPA99003430A (en) | 2000-04-24 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6060267A (en) | Production of vitamin B6 with an enzyme-containing cell extract | |
EP0765938B1 (en) | Fermentative production of vitamin B6 | |
EP0950715A2 (en) | Enzymatic production of vitamin B6 | |
US2978384A (en) | Method for the production of 1-glutamic acid | |
MXPA99003430A (en) | Enzymatic production of vitamin | |
JPH05123178A (en) | Production of l-phenylalanine | |
EP0076516B1 (en) | Method for fermentative production of l-proline | |
KR20050026531A (en) | Process for producing theanine | |
US4360594A (en) | Process for producing L-tryptophan or derivatives thereof using microorganisms | |
CN102586383A (en) | Process for preparing cytidine diphosphate choline | |
US7371547B2 (en) | Process for producing vitamin B6 | |
JPS6328596B2 (en) | ||
JPS6057833B2 (en) | Method for producing L-tryptophan | |
JPH027635B2 (en) | ||
EP0799895A1 (en) | Fermentative production of d-biotin | |
US3309285A (en) | Preparation of 5'-guanylic acid by fermentation | |
JPS6117475B2 (en) | ||
KR800000476B1 (en) | Method for preparation of adenosin by micro-organism | |
JPH06311891A (en) | Production of trehalose | |
US2798840A (en) | Production of vitamin b12 by agrobacterium radiobacter | |
JPS6128398A (en) | Preparation of l-valine | |
JPS58224695A (en) | Preparation of l-glutamic acid by fermentation | |
Sargeant et al. | The Production of L-Asparaginase from Erwinia carotovora | |
JPH11262398A (en) | Production of l-glutamic acid by fermentation | |
GB2052504A (en) | Process for the preparation of adenosine-5'-triphosphate by fermentation |